Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.

Authors: Minesh P. Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, David Roberge, Rosanda Ilic, Terence Tai Weng Sio, Daniel Michael Trifiletti, Thierry Muanza, Ana Misir Krpan, Naren R Ramakrishna, John B. Fiveash, Philippe Metellus, Chiachien Jake Wang, Loïc Feuvret, Christian Freyschlag, Tibor Csőszi, Paul D. Brown, Zhengfei Zhu, Jinming Yu, Maciej Harat

Published: 2024-06-04

DOI: 10.1200/jco.2024.42.16_suppl.2008

Source: Full article

---

Abstract

2008